title: Clinical considerations in managing nausea associated with venlafaxine.
authors.forename: J
authors.initials: J
authors.lastname: Amchin
authors.forename: D
authors.initials: D
authors.lastname: Albano
mesh_terms: D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects*; D020117:Cisapride; D003511:Cyclohexanols / Q000009:adverse effects*; D003866:Depressive Disorder / Q000188:drug therapy; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D009325:Nausea / Q000517:prevention & control*; D010880:Piperidines / Q000627:therapeutic use*; D000069470:Venlafaxine Hydrochloride
chemical_list: D018687:Antidepressive Agents, Second-Generation; D003511:Cyclohexanols; D005765:Gastrointestinal Agents; D010880:Piperidines; D000069470:Venlafaxine Hydrochloride; D020117:Cisapride